• Je něco špatně v tomto záznamu ?

Antiretroviral treatment of HIV infection does not influence HIV-specific immunity but has an impact on non-specific immune activation

Z. Bartovská, O. Beran, H. Rozsypal, M. Holub,

. 2011 ; 9 (2) : 88-94.

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12027776

HIV-specific and non-specific immune responses are crucial in the immunopathogenesis of HIV infection. Therefore, the objective of our study was to analyse the frequency and functional status of HIV-specific CD8+ T cells and the expression of non-specific activation markers on CD8+ T cells in HIV+ patients, and to assess the effects of combined antiretroviral treatment (cART). We examined 28 HIV+ patients, including 13 patients not receiving therapy and 15 patients on cART therapy using ELISpot assay and flow cytometry with intracellular and MHC tetramer staining. MHC tetramers detected HIV-specific CD8+ T cells in 6 HIV+ patients on cART and in 7 untreated individuals; the ELISpot method detected these cells in 5 untreated HIV+ individuals only. Reduced intracellular IFN-γ and IL-2 production by HIV-specific CD8+ T cells was detected in both treated and untreated HIV+ patients, and multifunctional CD8+ T cells simultaneously producing these cytokines were not found in any patient. In contrary to these findings, the percentage of CD8+ T cells expressing CD38 and HLA-DR was significantly higher in untreated patients as compared to HIV+ patients on cART. Together, these results suggest that the alterations of HIV-specific immunity are not influenced by the therapy of HIV infection; whereas, the non-specific chronic immune activation is down-regulated by cART.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12027776
003      
CZ-PrNML
005      
20160805131942.0
007      
ta
008      
120817s2011 ne f 000 0#eng||
009      
AR
024    7_
$a 10.2174/157016211795569078 $2 doi
035    __
$a (PubMed)21361861
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Bartovská, Zofia $u Department of Infectious and Tropical Diseases, First Faculty of Medicine, Charles University in Prague and University Hospital Bulovka, Czech Republic.
245    10
$a Antiretroviral treatment of HIV infection does not influence HIV-specific immunity but has an impact on non-specific immune activation / $c Z. Bartovská, O. Beran, H. Rozsypal, M. Holub,
520    9_
$a HIV-specific and non-specific immune responses are crucial in the immunopathogenesis of HIV infection. Therefore, the objective of our study was to analyse the frequency and functional status of HIV-specific CD8+ T cells and the expression of non-specific activation markers on CD8+ T cells in HIV+ patients, and to assess the effects of combined antiretroviral treatment (cART). We examined 28 HIV+ patients, including 13 patients not receiving therapy and 15 patients on cART therapy using ELISpot assay and flow cytometry with intracellular and MHC tetramer staining. MHC tetramers detected HIV-specific CD8+ T cells in 6 HIV+ patients on cART and in 7 untreated individuals; the ELISpot method detected these cells in 5 untreated HIV+ individuals only. Reduced intracellular IFN-γ and IL-2 production by HIV-specific CD8+ T cells was detected in both treated and untreated HIV+ patients, and multifunctional CD8+ T cells simultaneously producing these cytokines were not found in any patient. In contrary to these findings, the percentage of CD8+ T cells expressing CD38 and HLA-DR was significantly higher in untreated patients as compared to HIV+ patients on cART. Together, these results suggest that the alterations of HIV-specific immunity are not influenced by the therapy of HIV infection; whereas, the non-specific chronic immune activation is down-regulated by cART.
650    _2
$a dospělí $7 D000328
650    _2
$a látky proti HIV $x aplikace a dávkování $7 D019380
650    _2
$a antigeny CD38 $x biosyntéza $7 D051997
650    _2
$a CD8-pozitivní T-lymfocyty $x imunologie $7 D018414
650    _2
$a ELISPOT $7 D058501
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a průtoková cytometrie $7 D005434
650    _2
$a HIV $x imunologie $7 D006678
650    _2
$a HIV infekce $x farmakoterapie $x imunologie $7 D015658
650    _2
$a HLA-DR antigeny $x biosyntéza $7 D006684
650    _2
$a lidé $7 D006801
650    _2
$a interferon gama $x biosyntéza $7 D007371
650    _2
$a interleukin-2 $x biosyntéza $7 D007376
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a membránové glykoproteiny $x biosyntéza $7 D008562
650    _2
$a lidé středního věku $7 D008875
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Beran, Ondřej
700    1_
$a Rozsypal, Hanuš
700    1_
$a Holub, Michal $7 xx0018615
773    0_
$w MED00007898 $t Current HIV research $x 1873-4251 $g Roč. 9, č. 2 (2011), s. 88-94
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21361861 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120817 $b ABA008
991    __
$a 20160805132214 $b ABA008
999    __
$a ok $b bmc $g 949818 $s 785122
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 9 $c 2 $d 88-94 $i 1873-4251 $m Current HIV research $n Curr HIV Res $x MED00007898
LZP    __
$a Pubmed-20120817/11/03
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace